Related Experiment Video
Updated: Mar 14, 2026

09:11
Zika Virus Infectious Cell Culture System and the In Vitro Prophylactic Effect of Interferons
Published on: August 23, 2016
21.6K
Zika: an old virus with a new face
Tatjana Avšic Županc1, Miroslav Petrovec1
1University of Ljubljana, Faculty of Medicine, Institute of Microbiology and Immunology, Zaloška 4, 1000 Ljubljana, Slovenia.
Zdravstveno Varstvo
|October 6, 2016
Summary
Zika virus, a mosquito-borne flavivirus, caused a global health emergency after spreading from Brazil. The virus poses risks of neurological issues and congenital anomalies, with no current vaccine or treatment.
Area of Science:
- Virology
- Epidemiology
- Public Health
Background:
- Zika virus (ZIKV) is a mosquito-borne flavivirus previously confined to Africa and Asia.
- An outbreak in Brazil in 2015 led to rapid ZIKV spread across the Americas, causing a public health emergency.
- While often asymptomatic or mild, ZIKV infection is linked to severe neurological complications like Guillain-Barré syndrome and congenital anomalies such as microcephaly.
Purpose of the Study:
- To summarize the emergence and impact of Zika virus.
- To highlight the neurological and congenital risks associated with Zika virus infection.
- To outline current public health strategies for Zika virus prevention and control.
Main Methods:
- Literature review of Zika virus epidemiology and clinical manifestations.
- Analysis of public health responses and recommendations for Zika virus.
- Synthesis of information on ZIKV's transmission, risks, and prevention.
Main Results:
- Zika virus emerged in Brazil in 2015, spreading rapidly throughout the Americas.
- Neurological complications (e.g., Guillain-Barré syndrome) and congenital anomalies (e.g., microcephaly) are significant concerns.
- No specific antiviral treatments or vaccines are currently available for Zika virus.
Conclusions:
- The Zika virus epidemic necessitates a focus on infection prevention, especially for pregnant women.
- Public health efforts are concentrating on recommendations to minimize non-vector transmission.
- Continued vigilance and research are crucial for managing Zika virus risks.

